Pharma channel feed

Tor­na­do se­vere­ly dam­ages Pfiz­er's large ster­ile in­jectable plant in North Car­oli­na

Last year
Manufacturing

Tik­Tok takes down ac­counts for weight loss in­flu­encers who dis­cussed We­govy, Moun­jaro

Last year
Marketing

SEC fines for­mer Mer­ck ex­ec over in­sid­er trad­ing al­le­ga­tions

Last year
Law

WHO sounds the alarm over more con­t­a­m­i­nat­ed cough syrup in Africa

Last year
Manufacturing

Eu­ro­pean Com­mis­sion re­jects Ipsen's ul­tra-rare dis­ease drug af­ter two neg­a­tive opin­ions from EMA

Last year

Doc­tors with­out Bor­ders asks J&J not to en­force sec­ondary patents for TB drug af­ter gener­ic deal with non­prof­it

Last year
Deals

Strate­giz­ing a new drug launch? Don’t over­look soft skills for sales reps, whitepa­per says

Last year
Marketing

CMS pro­pos­es new cov­er­age pol­i­cy for Alzheimer's-re­lat­ed PET scans

Last year
FDA+

In­gre­di­ent man­u­fac­tur­er Cen­taur gets FDA warn­ing over records, sub­stan­dard clean­ing

Last year
FDA+
Manufacturing

Pieris Phar­ma­ceu­ti­cals lays off 70% of work­force af­ter As­traZeneca ends asth­ma med­i­cine part­ner­ship

Last year
People

Man­u­fac­tur­ers, in­dus­try groups com­ment on FDA’s con­trol over ni­trosamines in drug prod­ucts

Last year
FDA+
Manufacturing

J&J and Astel­las pile on two more bio­phar­ma in­dus­try law­suits over CMS drug price ne­go­ti­a­tions

Last year
Law

Mar­ket­ingRx roundup: Genen­tech, Bris­tol My­ers lead Fast Com­pa­ny in­no­va­tors list; Re­al Chem­istry inks AI deal  

Last year
Marketing

Meta’s new Threads: Is this a so­cial me­dia flash in the pan or re­al deal for phar­ma mar­keters?

Last year
Marketing

No­var­tis cuts PhII obe­si­ty can­di­date as it fi­nal­izes San­doz spin­off

Last year
R&D

EMA to drug de­vel­op­ers on AI: Car­ry out thor­ough risk as­sess­ments

Last year
AI

Om­ni­com Health Group re­brands net­work for the fu­ture with em­pha­sis on DE&I, da­ta

Last year
Marketing

FTC sues phar­ma da­ta gi­ant IQVIA to block pur­chase — and po­ten­tial ad­ver­tis­ing strong­hold

Last year
Marketing
Law

J&J's Ry­bre­vant-chemo com­bo shows pos­i­tive PFS da­ta in con­fir­ma­to­ry study

Last year
R&D

EU prepar­ing for pos­si­ble an­tibi­ot­ic short­age in the win­ter

Last year
Manufacturing

FDA ap­proves an­oth­er RSV op­tion, this time it's Sanofi and As­traZeneca’s an­ti­body drug for in­fants

Last year
FDA+

Sanofi, Doud­na-found­ed Scribe Ther­a­peu­tics to tar­get sick­le cell dis­ease in new pact

Last year
Deals

Apel­lis shares tum­ble on re­ports of eye in­flam­ma­tion in pa­tients tak­ing Syfovre

Last year
R&D

Up­dat­ed: Eli Lil­ly ex­pects FDA de­ci­sion on Alzheimer’s drug by end of year as it un­veils full PhI­II da­ta

Last year
R&D
First page Previous page 114115116117118119120 Next page Last page
A service from the Financial Times